Background: Although important for dosing and dilution, there are few data describing botulinum toxin (BT) movement in human muscle.
Objective: To better understand BT movement within human muscle.
Design: Proof-of-concept study with descriptive case series.
The aim of this work was to quantitatively model cross-sectional relationships between structural connectome disruptions caused by cerebral infarction and measures of clinical performance. Imaging biomarkers of 41 ischemic stroke patients (72.0 ± 12.
View Article and Find Full Text PDF